Skip to main content

Advertisement

SpringerLink
Log in

Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Paraoxonase is an HDL-associated enzyme that plays a preventive role against oxidative stress, which is thought to contribute to cancer development. PON1 activity varies widely among individuals, which is in part related to two common nonsynonymous polymorphisms in the PON1 gene (Q192R and L55M). The polymorphisms in PON1 have been implicated in cancer risk. However, results from the studies to date have been conflicting. To clarify the association, a meta-analysis was performed for 7,073 cases and 9,520 controls from 25 published case–control studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. Significant associations between PON1-L55M but not Q192R polymorphism and total cancer were observed from all the comparisons. In stratified analyses, PON1-55M allele was a risk factor for breast cancer. Similarly, increased risk was observed for prostate cancer (OR = 1.18, 95% CI: 1.01–1.36, P heterogeneity = 0.260) and Caucasian population (OR = 1.18, 95% CI: 1.02–1.38, P heterogeneity = 0.1) of the LM genotype, compared with the LL genotype. For PON1-Q192R polymorphism, PON1-192R allele was a decreased risk factor for cancer in the Asian group (RR vs QQ: OR = 0.61, 95% CI: 0.38–0.98, P heterogeneity = 0.268; QR vs QQ: OR = 0.71, 95% CI: 0.52–0.96, P heterogeneity = 0.130; RR + QR vs QQ: OR = 0.71, 95% CI: 0.53–0.95, P heterogeneity = 0.135). Although some modest bias could not be eliminated, this meta-analysis suggests that the PON1-55M allele is a risk factor for the development of cancer, in particular for breast cancer. Future studies with larger sample sizes are warranted to further evaluate these associations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, Garcia-Cabezas MA, Vara JA, Dominguez-Caceres A, Perona R, Gonzalez-Baron M (2004) Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15(7):707–719. doi:10.1023/B:CACO.0000036189.61607.52

    Article  PubMed  Google Scholar 

  2. Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221(4617):1256–1264

    Article  PubMed  CAS  Google Scholar 

  3. Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267. doi:10.1146/annurev.pharmtox.44.101802.121851

    Article  PubMed  CAS  Google Scholar 

  4. Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313(1):17–29

    PubMed  CAS  Google Scholar 

  5. Stevens VL, Rodriguez C, Talbot JT, Pavluck AL, Thun MJ, Calle EE (2008) Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II nutrition cohort. Prostate 68(12):1336–1340. doi:10.1002/pros.20796

    Article  PubMed  Google Scholar 

  6. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3(1):73–76. doi:10.1038/ng0193-73

    Article  PubMed  CAS  Google Scholar 

  7. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14(3):334–336. doi:10.1038/ng1196-334

    Article  PubMed  CAS  Google Scholar 

  8. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394(6690):284–287. doi:10.1038/28406

    Article  PubMed  CAS  Google Scholar 

  9. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Nacak M, Tapanyigit EE, Roots I (1999) Paraoxonase 1 mutations in a Turkish population. Toxicol Appl Pharmacol 157(3):174–177. doi:10.1006/taap.1999.8690

    Article  PubMed  CAS  Google Scholar 

  10. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT (2008) Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 17(8):2070–2077. doi:10.1158/1055-9965.EPI-08-0145

    Article  PubMed  CAS  Google Scholar 

  11. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1997) Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 122(2):265–268. doi:10.1038/sj.bjp.0701390

    Article  PubMed  CAS  Google Scholar 

  12. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE (2000) Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10(9):767–779

    Article  PubMed  CAS  Google Scholar 

  13. Leviev I, Negro F, James RW (1997) Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol 17(11):2935–2939

    Article  PubMed  CAS  Google Scholar 

  14. Leviev I, Deakin S, James RW (2001) Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res 42(4):528–535

    PubMed  CAS  Google Scholar 

  15. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, Berkkan H (2011) Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res 31(6):2225–2229

    PubMed  CAS  Google Scholar 

  16. Gallicchio L, McSorley MA, Newschaffer CJ, Huang HY, Thuita LW, Hoffman SC, Helzlsouer KJ (2007) Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev 31(2):95–101. doi:10.1016/j.cdp.2007.02.004

    Article  PubMed  CAS  Google Scholar 

  17. Searles Nielsen S, Mueller BA, De Roos AJ, Viernes HM, Farin FM, Checkoway H (2005) Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect 113(7):909–913

    Article  PubMed  Google Scholar 

  18. Arpaci A, Gormus U, Dalan B, Berkman S, Isbir T (2009) Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population. In Vivo 23(3):421–424

    PubMed  CAS  Google Scholar 

  19. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E (2005) Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63(3):240–251. doi:10.1002/pros.20184

    Article  PubMed  CAS  Google Scholar 

  20. Martinez C, Molina JA, Alonso-Navarro H, Jimenez-Jimenez FJ, Agundez JA, Garcia-Martin E (2010) Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol 10:71. doi:10.1186/1471-2377-10-71

    Article  PubMed  Google Scholar 

  21. Handoll HH (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87(6):875. doi:10.1016/j.apmr.2006.04.006

    Article  PubMed  Google Scholar 

  22. Midgette AS, Wong JB, Beshansky JR, Porath A, Fleming C, Pauker SG (1994) Cost-effectiveness of streptokinase for acute myocardial infarction: a combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making 14(2):108–117

    Article  PubMed  CAS  Google Scholar 

  23. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826

    PubMed  CAS  Google Scholar 

  24. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  25. Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crino L, Barberini F, Rulli A (2009) CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9:115. doi:10.1186/1471-2407-9-115

    Article  PubMed  Google Scholar 

  26. Uyar OA, Kara M, Erol D, Ardicoglu A, Yuce H (2011) Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer. Genet Mol Res 10(1):133–139. doi:10.4238/vol10-1gmr927

    Article  PubMed  CAS  Google Scholar 

  27. Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD (2008) Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 10(5):709–715. doi:10.1215/15228517-2008-037

    Article  PubMed  CAS  Google Scholar 

  28. Ozturk O, Kagnici OF, Ozturk T, Durak H, Tuzuner BM, Kisakesen HI, Cakalir C, Isbir T (2009) 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer. Anticancer Res 29(10):4041–4046

    PubMed  CAS  Google Scholar 

  29. Ergen A, Kilicoglu O, Ozger H, Agachan B, Isbir T (2011) Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma. Mol Biol Rep 38(6):4181–4184. doi:10.1007/s11033-010-0538-8

    Article  PubMed  CAS  Google Scholar 

  30. Hussein YM, Gharib AF, Etewa RL, ElSawy WH (2011) Association of L55 M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance. Mol Cell Biochem 351(1–2):117–123. doi:10.1007/s11010-011-0718-4

    Article  PubMed  CAS  Google Scholar 

  31. Lee CH, Lee KY, Choe KH, Hong YC, Kim YD, Kang JW, Kim H (2005) Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J Prev Med Public Health 38(3):345–350

    PubMed  Google Scholar 

  32. Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A (2002) Association between xenobiotic gene polymorphisms and non-Hodgkin’s lymphoma risk. Br J Haematol 118(2):477–481

    Article  PubMed  CAS  Google Scholar 

  33. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A (2004) Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89(5):628–629

    PubMed  CAS  Google Scholar 

  34. Sun Y (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8(6):583–599

    Article  PubMed  CAS  Google Scholar 

  35. Karaman E, Uzun H, Papila I, Balci H, Ozdilek A, Genc H, Yanardag H, Papila C (2010) Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma. J Craniofac Surg 21(6):1745–1749. doi:10.1097/SCS.0b013e3181f4040a

    Article  PubMed  Google Scholar 

  36. Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S (2007) Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 7:48. doi:10.1186/1471-2407-7-48

    Article  PubMed  Google Scholar 

  37. Akcay MN, Polat MF, Yilmaz I, Akcay G (2003) Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology 50(2):ccxxv–ccxxvii

    PubMed  Google Scholar 

  38. Akcay MN, Yilmaz I, Polat MF, Akcay G (2003) Serum paraoxonase levels in gastric cancer. Hepatogastroenterology 50(2):cclxxiii–cclxxv

    PubMed  Google Scholar 

  39. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99(1):62–66. doi:10.1172/JCI119134

    Article  PubMed  CAS  Google Scholar 

  40. Naidu R, Har YC, Taib NA (2010) Genetic Polymorphisms of paraoxonase 1 (PON1) Gene: association Between L55 M or Q192R with breast cancer risk and clinico-pathological parameters. Pathol Oncol Res. doi:10.1007/s12253-010-9267-5

  41. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34(6):1319–1328. doi:10.1093/ije/dyi169

    Article  PubMed  Google Scholar 

  42. Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2(4):903–917

    Article  PubMed  CAS  Google Scholar 

  43. Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A (2007) Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 40(15):1129–1134. doi:10.1016/j.clinbiochem.2007.06.007

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Laboratory, Xuzhou Children’s Hospital, No. 18 Sudi North Road, Xuzhou, 221006, Jiangsu Province, China

    Dai-Hua Fang, Juan Li & Lu Wang

  2. Division of Anesthesiology, Xuzhou Children’s Hospital, No. 18 Sudi North Road, Xuzhou, 221006, Jiangsu Province, China

    Cong-Hai Fan

  3. Division of Hematology, Xuzhou Children’s Hospital, No. 18 Sudi North Road, Xuzhou, 221006, Jiangsu Province, China

    Qiang Ji

  4. Intensive Care Unit, Xuzhou Children’s Hospital, No. 18 Sudi North Road, Xuzhou, 221006, Jiangsu Province, China

    Bo-Xiang Qi

Authors
  1. Dai-Hua Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cong-Hai Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiang Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo-Xiang Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cong-Hai Fan.

Additional information

Dai-Hua Fang and Cong-Hai Fan are contributed equally to this work and should be considered as co-first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 67 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fang, DH., Fan, CH., Ji, Q. et al. Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies. Mol Biol Rep 39, 6801–6809 (2012). https://doi.org/10.1007/s11033-012-1505-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1505-3

Keywords

Search

Navigation